DOYLESTOWN, Pa.--(BUSINESS WIRE)--OrthogenRx Inc. has announced the US Food and Drug Administration (FDA) approval of GenVisc 850 ® (sodium hyaluronate) for the treatment of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results